Varicella-zoster virus (VZV) glycoproteins gH and gL were examined in a recombinant vaccinia virus system. Single expression of glycoprotein gL produced two molecular forms : an 18 kDa form and a 19 kDa form differing in size by one endoglycosidase H-sensitive N-linked oligosaccharide. Coexpression of gL and gH resulted in binding of the 18 kDa gL form with the mature form of gH, while the 19 kDa gL form remained uncomplexed. The glycosylation processing of gL was not dependent on gH ; however, gL was required for the conversion of precursor gH (97 kDa) to mature gH (118 kDa). Subsequent analyses indicated that gL (18 kDa) was a more completely processed gL (19 kDa). Screening of the culture media revealed that gH and gL were secreted, but only if coexpressed and complexed together. The secreted form of gL was 18 kDa while that of gH was 114 kDa. The fact that secreted gH was smaller than intracytoplasmic gH suggested a proteolytic processing event prior to secretion. The 19 kDa form of gL was never secreted. These findings support a VZV gL recycling pathway between the endoplasmic reticulum and the cis-Golgi apparatus.
Introduction
Varicella-zoster virus (VZV), like other herpesviruses, encodes a number of structural glycoproteins that enable the virus to successfully accomplish its assembly and trafficking. Two glycoproteins, gH and gL, are functionally conserved across all herpesviruses. Previous studies provide evidence that gH is responsible for cell fusion, and that mature glycosylation is essential for its fusogenic function (Forrester et al., 1992 ; Fuller & Lee, 1992 ; Peeters et al., 1992) . Monoclonal antibodies against gH are able to inhibit virus entry, egress and cell-to-cell spread of VZV infection in cultured cells (Montalvo et al., 1986 ; Rodriguez et al., 1993) . The gH protein has been found to form a complex with a gL counterpart in all three subfamilies of herpesviruses (Forghani et al., 1994 ; Kaye et al., 1992 ; Hutchinson et al., 1992 ; Liu et al., 1993 ; Klupp et al., 1994 ; Stokes et al., 1996) . The association of gH with gL is required for correct folding, complete processing, intracellular trafficking and antigenic properties of gH. The scheme by Author for correspondence : Lucie Mares) ova! .
Fax j420 2 21977392. e-mail lucie-maresova!uiowa.edu which the gH : gL complex participates in virus entry and cellto-cell spread has not been established yet, but the evolutionary conservation of the complex suggests that it has an essential role in the VZV infectious cycle. The gH : gL association is mediated by noncovalent protein-to-protein interactions in VZV (Duus et al., 1995) , herpes simplex virus type 1 (HSV-1 ; Hutchinson et al., 1992) and Epstein-Barr virus (EBV ; Li et al., 1995) , while disulfide linkages are an important feature of the gH : gL complex in human herpesvirus-6 and human cytomegalovirus (HCMV) (Anderson et al., 1996 ; Kaye et al., 1992) .
Unlike gH, the gL genes are not well conserved among herpesviruses. Typically, gL has an N-terminal hydrophobic domain characteristic of a signal sequence ; however, gL has no other predicted membrane-spanning domains. Not only is VZV gL smaller than HSV-1 gL, but it also lacks a typical Nterminal endoplasmic reticulum (ER) signal sequence (Davison & Scott, 1986) . On the other hand, VZV gL possesses a 16 residue sequence which is common with members of the ERtargeting family of proteins (Duus et al., 1995) . In the absence of gH, the gL proteins are either secreted, as is the case of HCMV gL (Spaete et al., 1993) and HSV-1 gL (Dubin & Jiang, 1995) , or they are found as type 2 membrane proteins, like EBV gL (Li et al., 1995) . A model of post-translational VZV gH : gL regulation was proposed whereby the gL chaperone modulated gH expression via retrograde flow from the Golgi apparatus to the ER (Duus & Grose, 1996) .
It has been reported that in certain herpesviruses, additional viral glycoproteins or cellular proteins are required for proper gH : gL interaction (L. Wang et al., 1998) . For example, glycoprotein O has been found to be associated with gH : gL in HCMV virions (Huber & Compton, 1997 . Moreover, EBV has added a unique glycoprotein, gp42, for proper gH : gL complex formation (gH : gL : gp42). This specific adaptation of EBV is required for infection of B lymphocytes (Li et al., 1995) . The differences in gH : gL can reflect various models of virus penetration into different cell types and a different tropism of the virus. It remains to be determined whether VZV and the other members of the alphaherpesvirus subfamily require another component in addition to the gH : gL complex. In this work, formation of the VZV gH : gL complex was analysed in greater detail through the use of a recombinant vaccinia virus expression system.
Methods

Construction of vaccinia virus recombinants.
Vaccinia virus (VV) strain Praha was used for construction of all recombinants (Kutinova! et al., 1995) . Fig. 1 shows the simplified design of single and double recombinants containing the VZV genes gH (ORF 37), gL (ORF 60), gB (ORF31) and gE (ORF 68), which were inserted into the thymidine kinase (TK) or haemagglutinin (HA) genes of the VV. Expression of the extrinsic genes was controlled either by the early\late VV p7n5 promoter or by the late VV 11k promoter. The recombination and TK selection were performed as described by Perkus et al. (1986) . The recombinant viruses with the foreign gene inserted in the HA gene were isolated from plaques that were negative in haemadsorption (Shida & Matsumoto, 1983) . The Esherichia coli xanthine-guanidine phosphoribosyl transferase (gpt) gene under control of the VV I $ promoter served as a selection marker for recombinant viruses (Boyle & Coupar, 1988) . All recombinant viruses were plaque purified three times.
The construction of the single recombinant viruses expressing gH (VV-gH) and gL (VV-gL) was described in detail previously (Ne) mec) kova ! et al., 1996) . To prepare VV-gB recombinant, the VZV gB gene (Davison & Scott, 1986 ) was amplified by PCR utilizing primers gB-1, 5h CGGAATTCGCCATGCCCGGCGTTTTCATAACC 3h, and gB-2, 5h CTGTGAAGCTTAATGGAGACACATG 3h. Plasmid VZV-HindIII D was used as a template DNA (Ecker & Hyman, 1982) . During PCR amplification, a signal sequence of 8 amino acids was extended from the 5h end to include 21 additional amino acids (a total of 29) for efficient expression of gB, according to Massaer et al. (1993) . The amplified gB gene was then cloned into the plasmid p-gpt-ATA 18-2 (kindly provided by H. Stunnenberg, Heidelberg, Germany) and then cleaved with EcoRI and HindIII restriction enzymes. The final plasmid, pgB, was used for the generation of the VV-gB recombinant by the gpt selection system.
The double recombinant VV-gEjgB was generated by recombination of the VV-gE-HA virus with the pgB plasmid. Construction of the VV-gE-HA recombinant, which expresses the gE gene inserted in the HA gene, was described previously by Kutinova! et al. (1999) . For the construction of the double recombinant VV-gHjgL, the pgL plasmid containing the gL gene (Ne) mec) kova ! et al., 1996) was digested with NruI and HindIII, and its cohesive ends were filled by Klenow enzyme. This fragment, containing the gL gene, the VV 11k promoter and the gpt gene (under control of the VV I $ promoter), was cloned in the NruI site of pVV-HA plasmid (Kutinova! et al., 1999) . The resulting plasmid pgL-HA was used for recombination with the single VV-gH recombinant. Vaccinia virus VV-E\L-lacZ, which expresses β-galactosidase, was prepared by recombination with plasmid pMJ601 (Davison & Moss, 1990) .
Antibodies. Human anti-gH specific V $ MAb, which recognizes a conformation-dependent virus-neutralization epitope (Sugano et al., 1991) , and human anti-gB specific V " MAb (obtained from T. Sugano, Tokyo, Japan) were used at a stock concentration of 1 mg\ml. High VZV titre serum from a herpes zoster patient was precleared by absorption with VV antigens (Ne) mec) kova ! et al., 1996) , and shown to be free of anti-VV antibodies by ELISA with VV antigens. Rabbit antiserum 60A was raised against a synthetic peptide fragment of the VZV gL. The immunogenic peptide GEEHKSGDIRD predicted by the ANTIGEN program (PCgene, Intelli Genetics) corresponds to amino acid residues 111-121 of the gL sequence. The synthetic peptide coupled to keyhole limpet haemocyanin (Sigma) was used for immunization according to a standard protocol (Harlow & Lane, 1988) .
Radioimmunoprecipitation procedures.
Overnight-cultured CV-1 cells (6i10&) were starved for 3 h in methionine\cysteine-deficient Dulbecco's modified Eagle medium (Sigma) (labelling medium) supplemented with 10 % foetal bovine serum and -glutamine (0n58 µg\ml). Infection with VV recombinant viruses was performed at an m.o.i. of 5 p.f.u. per cell. A mixture of [$&S]methionine\[$&S]cysteine of 83 µCi (Pro-Mix, Amersham) in 1 ml of labelling medium was added at the same time. The cell cultures were incubated for 18 h, then harvested, washed with PBS and lysed for 30 min on ice with 0n2 ml of lysis buffer (50 mM Tris-HCl pH 8n0, 150 mM NaCl, 1 % NP-40) containing the protease inhibitor cocktail (1 µg\ml aprotinin, 1 µg\ml leupeptin, 1 µg\ml pepstatin, 44 µg\ml PMSF, 50 µg\ml TLCK and 90 µg\ml TPCK). The cell lysates were clarified by centrifugation at 19 000 g for 10 min at 4 mC.
Prior to harvesting the culture medium was removed from radiolabelled CV-1 cells and immediately treated with the protease inhibitor cocktail, and centrifuged gently at 300 g for 10 min at 4 mC to remove dead cells and other cellular debris. The medium was then centrifuged at 100 000 g for 1 h. The supernatant was removed and concentrated tenfold in Centricon-10 concentrator tubes (Amicon) at 4 mC and incubated with the same volume of 2i lysis buffer for 30 min on ice.
Both the lysates and the media were precleared by incubation with 10 µl of human VZV-negative serum for 1 h on ice. The immune complexes were removed by 10 µl Protein A-Sepharose beads (Sigma). For immunoprecipitation of VZV glycoproteins, 25 µl of either MAbs or serum from the zoster patient was added and the samples were incubated for 1 h on ice. Precipitates were collected on Protein A-Sepharose beads. After overnight incubation, the beads were washed in lysis buffer, resuspended in Laemmli sample buffer and heated at 95 mC for 10 min.
Immunoprecipitated proteins were analysed by gradient (7n5-20 % polyacrylamide) SDS-PAGE under reducing conditions (Laemmli sample buffer with 5 % β-mercaptoethanol) (Laemmli, 1970) . Protein mobility was calibrated by unlabelled and "%C-radiolabelled molecular mass standards (Biorad, Amersham). Gels were incubated with Amplify (Amersham), dried and exposed to autoradiographic film Hyperfilm-βmax (Amersham).
Treatment with glycosidases.
The immune complexes collected on Protein A-Sepharose beads were washed with lysis buffer and PBS. For endoglycosidase H (Endo H) digestion, proteins were dissociated from the beads by heating at 95 mC for 6 min in 35 mM Na\phosphate, pH 5n4, 0n7 % SDS, 3n5 mM dithiothreitol. The eluted material was then diluted with 4 vols of 35 mM Na\phosphate, pH 5n4 and incubated for 24 h at 37 mC with or without 20 mU Endo H (Boehringer) per ml. For peptide : N-glycosidase F (PNGase F) digestion, proteins were dissociated from the beads by heating at 95 mC for 6 min in 0n1 M Na\phosphate, pH 8n6, 0n2 % SDS, 10 mM EDTA, 0n1 mM PMSF, 5 % β-mercaptoethanol. The eluted material was then diluted with 2 vols of 0n5 % octyl β--glucopyranoside, and incubated for 24 h at 37 mC with or without 3 U PNGase F (Boehringer) per ml. Deglycosylated proteins were precipitated with 80 % acetone.
Results
VZV gH : gL complex synthesized by the double VV-gHMgL recombinant
As we showed previously, coinfection of CV-1 cells with VV-gH and VV-gL recombinant viruses resulted in the formation of a gH : gL complex that carried the conformationdependent virus-neutralizing epitope (Ne) mec) kova ! et al., 1996) . To study this complex in detail, we prepared the double VVgHjgL recombinant. It not only resulted in a higher level of gH : gL synthesis but, more importantly, guaranteed coexpression in every infected cell, which better mimicked the natural VZV infection. In lysates of CV-1 cells infected with VV-gHjgL, we found a mature gH molecule of 118 kDa and an 18 kDa form of gL, which were coprecipitated with the zoster serum (Fig. 2, lane 5) . In CV-1 cells infected with VV-gH alone, the gH form of 97 kDa was detected (Fig. 2) . This incompletely glycosylated precursor of gH (pre-gH) was recognized by serum from the zoster patient (lane 4) but not by V $ MAb (not shown). No specific product was immunoprecipitated from the cells infected with VV-gL alone (lane 6). Thus, coexpression of gH and gL resulted in complete gH processing and formation of the conformational epitope recognized by V $ MAb (see Fig. 4 A, lanes 3 and 6). VZV glycoproteins gB and gE were similarly expressed as a control for secretion of VZV gH and gL (see later).
Heterogeneity of VZV gL
Since no convalescent zoster sera tested can precipitate gL selectively, we prepared the rabbit 60A antiserum raised against a predicted immunogenic peptide corresponding to the amino acid sequence spanning the residues 111-121 of the gL molecule (Davison & Scott, 1986) . Two forms of gL were detected in the lysate from the VV-gL-infected CV-1 cells using this antiserum (Fig. 3, lane 3) . The 18 kDa mass of the smaller protein was consistent with gL precipitated with serum from the zoster patient or V $ MAb in the gH : gL complex after infection with the double VV-gHjgL recombinant (Fig. 4 C, lane 2 and Fig. 4 A, lanes 3 and 6) . The second gL form migrated at a slightly but perceptively higher molecular mass of 19 kDa.
When the extract of CV-1 cells infected with VV-gHjgL was precipitated by 60A antiserum, only the 19 kDa gL form was detected (Fig. 3, lane 4) ; no 18 kDa gL form was seen.
BFEH L. Mares) ova! and others L. Mares) ova! and others 35 S]cysteine/methionine. Cell lysates were precipitated with serum from a zoster patient. Immunoprecipitates were analysed by SDS-PAGE using a gradient gel under reducing conditions. Molecular mass markers and VZV glycoprotein positions are indicated ; gL is the 18 kDa form. All samples were analysed on the same gel. Immunoprecipitates were analysed by SDS-PAGE using a gradient gel under reducing conditions. Molecular mass markers and the positions of gL forms are indicated. All samples were analysed on the same gel. Also, the 60A antiserum was not able to coprecipitate gH (Fig.  3, lanes 2 and 4) . This result indicated that in the case of gHjgL coexpression, the epitope recognized by 60A serum was accessible only on the 19 kDa gL form ; in other words, complex formation obscured or altered the same epitope. The 19 kDa gL form, which remained uncomplexed with gH, was not precipitated by V $ MAb or zoster patient serum. The relative amount of the 19 kDa gL form precipitated by 60A antiserum was not different when expressed by the single VVgL recombinant or coexpressed with gH by the VV-gHjgL recombinant (Fig. 3, lanes 3 and 4) . Both gL forms were produced in comparable amounts. As all 18 kDa gL was bound in the gH : gL complex, it did not influence the amount of 19 kDa gL being produced.
Release of the VZV gH : gL complex into culture media
To test whether VZV glycoproteins were secreted from the CV-1 cells, we analysed the culture media of cells infected with the VV recombinants and their various coinfection mixtures (Fig. 5) . In cells that coexpressed gHjgL, gH was secreted in the complex with gL (lane 4). The molecular mass of the secreted gH (precipitated by serum from a zoster patient or V $ MAb) was approximately 114 kDa, which was lower by 4-5 kDa than the mature intracellular gH (118 kDa) (Fig. 4 B , lane 2 and Fig. 4 A, lanes 3 and 6 ). An intermediate 97 kDa form of gH produced by the simple VV-gH recombinant in cell lysates (Fig. 2, lane 4) was not identified in the culture medium (Fig. 5, lane 3) . Results in Figs 4 and 5 show that gL was detected in the culture medium only if coprecipitated by V $ MAb or serum from a zoster patient. This secreted gL form (Fig. 4 A, lanes 3 and 6) had the same molecular mass of 18 kDa as that of gL coprecipitated (by V $ MAb or zoster patient serum) in the complex with gH from the cell lysates (Fig. 4 A, lanes 3 and 6 and Fig. 4 C, lane 2) . The 60A antiserum was not able to precipitate any gL molecule from the culture medium of the cells infected with the VV-gL recombinant alone (Fig. 4 A,  lanes 2 and 5) . Thus, gL was detected in media only when associated with the secreted gH form.
VZV gE and gB were selected as examples of glycoproteins that were secreted or remained cell-associated, respectively. After precipitation with zoster patient serum the gE protein was processed to a 95-97 kDa molecule (Fig. 2, lane 3) . Recombinant gB was detected by serum from a zoster patient as a doublet corresponding to 66-68 kDa (Fig. 2, lanes 2 and  3) on SDS-PAGE under reducing conditions. Analysis of the distribution of gE and gB revealed secretion of gE into media. The extracellular flow of gE may be related to the strong sorting information on the gE molecule for its targeting from the trans-Golgi network to the cell surface (Zhu et al., 1996 ; Olson & Grose, 1997) .
Finding the VZV glycoproteins in culture medium cannot be attributed solely to the CV-1 cells damaged upon VV infection. We did not detect any β-galactosidase activity as a BFEI Fig. 4 . Analysis of VZV gL and gH by endoglycosidases. CV-1 cells were infected with VV recombinants and labelled with [ 35 S]cysteine/methionine. Medium removed from the labelled cells was centrifuged for 1 h at 100 000 g, concentrated tenfold in Centricon-10 concentrator tubes, and immunoprecipitated with anti-peptide gL serum 60A, gH-specific human V 3 MAb or serum from a zoster patient. Immunoprecipitates were incubated with or without endoglycosidase H (Endo H) or peptide : Nglycosidase F (PNGase F). The samples were analysed by SDS-PAGE using a gradient gel under reducing conditions. C, Material from cell lysates ; M, material from culture media. Molecular mass markers and VZV glycoprotein positions are indicated ; gL* and gH* represent the deglycosylated products of gL and gH respectively. (A) Wild-type VV (lanes 1 and 4) , VV-gL (lanes 2 and 5), VV-gHjgL (lanes 3 and 6). (B, C) Wild-type VV (lane 1), VV-gHjgL (lane 2).
leakage marker in the culture medium of the control experiment with infection of the VV-lacZ recombinant virus alone (Fig. 6) .
Analysis of glycosylation patterns of VZV gH and gL
The oligosaccharide processing of gH and gL expressed by VV-gHjgL in cell lysates and culture media was investigated by determining the sensitivity of the glycoproteins to treatment with glycosidases Endo H and PNGase F (Fig. 4) . The molecular mass of the intracellular 118 kDa gH form was not reduced greatly by Endo H digestion (Fig. 4 A, lane 3 C) . The complete removal of N-linked oligosaccharides from the 118 kDa gH form by PNGase F digestion resulted in a loss of BFEJ L. Mares) ova! and others L. Mares) ova! and others 35 S]cysteine/methionine. Medium removed from the labelled cells was centrifuged for 1 h at 100 000 g, concentrated tenfold in Centricon-10 concentrator tubes and then subjected to immunoprecipitation with serum from a zoster patient. Immunoprecipitates were analysed by SDS-PAGE using a gradient gel under reducing conditions. Molecular mass markers and VZV glycoprotein positions are indicated ; gL is the 18 kDa form. (Sambrook & Maniatis, 1989) . molecular mass of about 40 kDa (Fig. 4 A, lane 6 and Fig. 4 B) . This result demonstrated that the mature intracellular gH carried predominantly Endo H-resistant (complex-type Nlinked) oligosaccharides, a finding consistent with a previous study demonstrating that gH is sialated on N-linked sugars (Montalvo & Grose, 1986) . The secreted 114 kDa gH form was digested by Endo H to a product which migrated at a similar mass to the intracellular form treated with Endo H. As shown in Fig. 4 (A, lane 6) and Fig. 4 (B, lane 2) , the molecular mass of the secreted 114 kDa gH and intracellular gH after PNGase F treatment differed by 4-5 kDa. There was no evidence for a difference in sugars between the secreted form and the intracellular form of gH.
An analysis of gL expressed after VV-gHjgL infection revealed that the 18 kDa gL form precipitated from the cell lysates was digested by Endo H (Fig. 4 C, lane 2 and Fig. 4 A, lane 3) with a decrease in molecular mass of about 4 kDa. An analogous shift in mobility was observed after PNGase F digestion (Fig. 4 A, lane 6 ). This finding suggested that one high-mannose\hybrid-type N-linked oligosaccharide was removed. Furthermore, the glycosidase results were the same for both intracellular and secreted 18 kDa gL (Fig. 4 C, lane 2 and Fig. 4 A, lanes 3 and 6), indicating that processing of gL was not changed by trafficking of the gH : gL complex to the culture media.
The deglycosylation pattern of both forms of gL detected by the 60A antiserum was tested after single VV-gL expression in the cell lysates (Fig. 4 A, lanes 2 and 5) . The same downward shift to approximately 14 kDa occurred for both the 18 kDa and 19 kDa gL form after digestion by either glycosidase. Thus, both forms of gL differ in processing of one high mannose or hybrid-type N-linked oligosaccharide. Since the analogous result about deglycosylation of 18 kDa gL was obtained from single VV-gL and double VV-gHjgL expression (Fig. 4 A, lanes 2-3 and 5-6, respectively), we infer that the maturation of gL was not influenced by coexpression and complex formation with gH.
Discussion
The majority of the recent studies on interaction of VZV glycoproteins has been performed using the VV-T7 polymerase transfection system (Duus et al., 1995 ; Duus & Grose, 1996 ; Q. Li et al., 1997 ; Olson & Grose, 1998 ; Ye et al., 1999) . We have used an expression system where VZV glycoprotein genes were inserted into recombinant VV. This approach enabled us to infect cells at a high virus multiplicity with subsequent high expression and efficient coexpression of foreign genes. We were able to detect molecular forms of VZV glycoproteins which were not previously observed in other experimental systems.
A heterogeneous molecular pattern of VZV gL was identified for CV-1 cells infected with a single VV-gL recombinant. Two gL forms, of 18 kDa and 19 kDa, were detected by the 60A antiserum recognizing amino acid residues 111-121 of the gL sequence. Analysis of the oligosaccharide moiety revealed that both forms of gL differed only in the processing of one N-linked oligosaccharide of high mannose\ hybrid-type sensitive to Endo H. It has been shown previously that gL does not change its molecular mass if expressed in the presence of monensin, which indicates that gL maturation does not require processing in the trans-Golgi system (Duus & Grose, 1996) . Our data on Endo H sensitivity localized the final oligosaccharide processing step of gL within the early part of the medial-Golgi system, according to the spectrum of glycosylation reactions within the Golgi system (Kornfeld & Kornfeld, 1985) .
The heterogeneity of gL forms has not been studied in detail to date. Only one band of gL was previously observed in the VV-T7 cotransfection systems with VZV glycoproteins, but two closely migrating gL species have appeared in cultured cells infected with natural VZV (Forghani et al., 1994) . We postulated that the processing of gL forms reflected a difference in their trafficking status. The localization could explain a selective distribution of the gL forms in complex with gH. Since both forms differed only in a subtle nuance in their glycosylation, the two gL forms may have the same potential for interacting with gH. If it is assumed that mature gL is found in complex with mature gH, then the 18 kDa gL form should be considered as the mature form ; the 19 kDa gL form would represent a premature gL containing non-trimmed oligosaccharides. Our results concerning the two gL forms are supported by diverse trafficking routes of VZV gL in the model proposed by Duus & Grose (1996) , which includes the Golgi-ER recycling of gL as well as the transport of the gH : gL complex through the Golgi apparatus to the outer cell membrane.
A hypothesis on the structure of the gH : gL complex can be drawn from the fact that 60A antiserum recognized only the non-complexed 19 kDa gL molecule. The gL amino acid sequence 111-121 is exposed on the surface of the gL molecule, but is hidden in the gH : gL complex. This region is in the relative vicinity of amino acid sequence 73-100, which is highly conserved for herpesviral gL homologues (Yoshida et al., 1994) and is a candidate for the ER-targeting motif on gL responsible for its Golgi-ER recycling (Duus & Grose, 1996) . We hypothesize that the ER-targeting motif on gL can be masked during complex formation with gH. Afterwards, the complex escapes the recycling, and allows gH to travel to the surface of the cell.
Our data showed that individually expressed gH was not secreted. Unlike gL of HSV-1, which is secreted from cells when expressed in the absence of gH (Dubin & Jiang, 1995) , we did not detect VZV gL in the media, unless it was coexpressed with gH. The differences between HSV and VZV gL include the following points. First, HSV-1 gL was found to be membrane-associated, most likely as a result of complex formation with gH (Dubin & Jiang, 1995) , whereas the VZV gL was not present on the surface of gH\gL cotransfected cells (Duus & Grose, 1996) . Second, coexpression of HSV-1 gH and gL is required for normal post-translational processing and intracellular transport of both gH and gL glycoproteins. Our experiments support earlier results where VZV gL processing was not dependent on gH. Third, gL VZV is half the size of HSV-1 gL.
Finally, we propose a model to explain VZV gH secretion. This model is based on the earlier work by Dubin & Jiang (1995) in which they truncated HSV-1 gH of its transmembrane domain and cytoplasmic tail. When this truncated gH construct was cotransfected with gL, both HSV-1 gL and gH were found in the medium. Similarly, we suggest that VZV gH is proteolytically cleaved at a similar location, although the site was not located.
